^
Association details:
| Biomarker: | CD69 overexpression |
|---|---|
| Cancer: | Melanoma |
| Drug Class: | PD1 inhibitor |
| Direction: | Sensitive |
Evidence:
Source:
Title:
CD69 and SBK1 as potential predictors of responses to PD-1/PD-L1 blockade cancer immunotherapy in lung cancer and melanoma
Published date:
08/15/2022
Excerpt:
Further analysis showed that in lung cancer responders, CD69 was upregulated while SBK1 was downregulated and that in melanoma responders, both were upregulated….CD69 and SBK1 are potential predictors of response to cancer immunotherapy using PD-1/PD-L1 blockade.
DOI:
10.3389/fimmu.2022.952059
